Literature DB >> 8646853

Kaposi's sarcoma with an intense parasitization by Leishmania.

M A Gallego1, A Aguilar, S Plaza, J M Gomez, F Burgos, J L Agud, J Marco, C García.   

Abstract

Visceral leishmaniasis has been reported as a complication in patients infected with human immunodeficiency virus (HIV) who live in areas where leishmaniasis is endemic or in patients who have traveled to these areas. Kaposi's sarcoma has been found frequently in patients with acquired immunodeficiency syndrome (AIDS). We report a HIV-infected patient having visceral leishmaniasis associated with Kaposi's sarcoma in which a biopsy specimen obtained from a pigmented cutaneous lesion revealed the coexistence of a Kaposi's sarcoma pattern with Leishmania parasitic colonization.

Entities:  

Mesh:

Year:  1996        PMID: 8646853

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  4 in total

1.  Canine transmissible venereal tumour parasitized by Leishmania infantum.

Authors:  G Catone; G Marino; G Poglayen; M Gramiccia; A Ludovisi; A Zanghì
Journal:  Vet Res Commun       Date:  2003-10       Impact factor: 2.459

2.  Atypical lesions as a sign of cutaneous dissemination of visceral leishmaniasis in a human immunodeficiency virus-positive patient simultaneously infected by two viscerotropic Leishmania species.

Authors:  Joanna R Santos-Oliveira; Alda M Da-Cruz; Lucy H S Pires; Elisa Cupolillo; Katrin Kuhls; Carmem B W Giacoia-Gripp; Manoel P Oliveira-Neto
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

3.  Visceral leishmaniasis revealed by a squamous cell carcinoma in an HIV-1 infected patient.

Authors:  P Donati; G Paolino; C Panetta; L Muscardin; C Cota; M Giuliani
Journal:  Infection       Date:  2013-02-03       Impact factor: 3.553

Review 4.  PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.

Authors:  Eduard E Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.